344 related articles for article (PubMed ID: 21411384)
1. Microvascular complications and risk factors in patients with type 2 diabetes.
Del Cañizo Gómez FJ; Fernández Pérez C; Moreno Ruiz I; de Gorospe Pérez-Jáuregui C; Silveira Rodríguez B; González Losada T; Segura Galindo A
Endocrinol Nutr; 2011 Apr; 58(4):163-8. PubMed ID: 21411384
[TBL] [Abstract][Full Text] [Related]
2. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
[TBL] [Abstract][Full Text] [Related]
3. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.
Tong PC; Lee KF; So WY; Ng MH; Chan WB; Lo MK; Chan NN; Chan JC
Diabetes Care; 2004 Jan; 27(1):216-22. PubMed ID: 14693992
[TBL] [Abstract][Full Text] [Related]
4. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
5. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
8. Microvascular complications and their associated risk factors in type 2 diabetes mellitus.
Khanam PA; Hoque S; Begum T; Habib SH; Latif ZA
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S577-S581. PubMed ID: 28455164
[TBL] [Abstract][Full Text] [Related]
9. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
Müller M; Schönfeld CL; Grammer T; Krane V; Drechsler C; Genser B; Kohnen T; Wanner C; März W
Sci Rep; 2020 Aug; 10(1):14158. PubMed ID: 32843669
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.
Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A
J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150
[TBL] [Abstract][Full Text] [Related]
13. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors associated with urinary albumin excretion in type II diabetes.
Savage S; Nagel NJ; Estacio RO; Lukken N; Schrier RW
Am J Kidney Dis; 1995 Jun; 25(6):836-44. PubMed ID: 7771479
[TBL] [Abstract][Full Text] [Related]
15. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
[TBL] [Abstract][Full Text] [Related]
17. Association of diabetic retinopathy, ischemic heart disease, and albuminuria with diabetic treatment in type 2 diabetic patients. A population-based study.
Weitzman S; Maislos M; Bodner-Fishman B; Rosen S
Acta Diabetol; 1997 Dec; 34(4):275-9. PubMed ID: 9451472
[TBL] [Abstract][Full Text] [Related]
18. Early-onset type 2 diabetes: A high-risk factor for proliferative diabetic retinopathy (PDR) in patients with microalbuminuria.
Lv X; Ran X; Chen X; Luo T; Hu J; Wang Y; Liu Z; Zhen Q; Liu X; Zheng L; Tang Y; Zhao Q; Han S; Zhou Y; Luo W; Yang L; Li Q; Wang Z
Medicine (Baltimore); 2020 May; 99(19):e20189. PubMed ID: 32384512
[TBL] [Abstract][Full Text] [Related]
19. Microvascular benefits of hypertension and glucose control in type 2 diabetes.
van Rensburg BW
Cardiovasc J Afr; 2008; 19(4):179-80. PubMed ID: 18776957
[No Abstract] [Full Text] [Related]
20. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
